1. Market Research
  2. > Healthcare
  3. > Medical Device Market Trends
  4. > MediPoint: Spinal Fusion - US Analysis and Market Forecasts

MediPoint: Spinal Fusion - US Analysis and Market Forecasts

Summary

Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure. Given the global phenomenon of an aging society and the associated increasing incidences of degenerative spinal conditions, the spinal fusion market is expected to remain strong over the forecast period.

The fastest growing segment within the spinal fusion market will be spinal plating systems, with a CAGR of 5.60%. The US pedicle screw systems market and the US interbody cages market will grow at similar rates over the forecast period.

Scope

- An overview of Spinal Fusion, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized the US Spinal Fusion market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Spinal Fusion.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Spinal Fusion sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving the US Spinal Fusion market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in the US Spinal Fusion market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in the US Spinal Fusion market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Spinal Fusion - US Analysis and Market Forecasts
1 Table of Contents

2 Introduction 12
2.1 Overview 12
2.2 Catalyst 12
3 Industry Overview 14
3.1 Indications 14
3.2 Types of Devices 16
3.2.1 Spinal Plating Systems 16
3.2.2 Interbody Cages 17
3.2.3 Pedicle Screw Systems 19
3.3 Procedure Trends 20
3.4 Market Access 21
3.4.1 Regulation 21
3.4.2 Adoption 22
3.4.3 Reimbursement Trends 24
4 Market Dynamics: Mergers, Acquisitions and Key Partnerships 28
4.1 Overview 28
4.1.1 Amedica Corporation Acquires US Spine 29
4.1.2 Alphatec Spine Acquires Scient'x Group 29
4.1.3 Biomet Acquires Lanx, Inc. 29
4.1.4 Globus Medical Acquires Facet Solutions 29
4.1.5 Integra LifeSciences Holdings Corporation Acquires SeaSpine, Inc. 30
4.1.6 Medtronic Acquires Advanced Medical Technologies and China's Kanghui 30
4.1.7 Nuvasive Acquires ANC 30
4.1.8 TranS1 Inc. Acquires Baxano Inc. 30
4.2 Economic Impact 31
5 Unmet Needs 34
5.1 Improved Reimbursement Coverage for Minimally Invasive Surgical Procedures 34
5.2 Lack of Definitive Methods to Determine Fusion Performance 35
5.3 Technological Developments in the Use of Long Fusions 35
5.4 Research and Development into Fusion Enhancers 37
5.5 Improve Osseointegration of Bone and Screw Interface 38
6 Market Opportunity Analysis 40
6.1 Develop Signature Minimally Invasive Technique 40
6.2 Market Minimally Invasive Training Opportunities to Fellowship Programs 41
6.3 Increased Collaboration of Medical Device Implants and Biologics 42
6.4 Develop a Device that Provides Real-Time Fusion Updates 43
6.5 Increased Customization of Spinal Implants to Patient Anatomy 43
7 Market Drivers 45
7.1 Aging Patient Populations 45
7.2 Growth in the Spinal Stenosis Indication 47
7.3 Gold Standard for Treating Spinal Instability and Degenerative Conditions 49
7.4 Treatment for a Variety of Indications 49
7.5 Preference for Minimally Invasive Techniques 50
7.6 Advances in Navigation Technology 52
8 Market Barriers 53
8.1 Incidence of Adjacent Segment Disease 53
8.2 Performance of Non-Fusion Technologies 53
8.3 Increased Scrutiny over Spinal Fusion's Necessity in the US 55
8.4 Restricted Reimbursement from Private Payers 56
8.5 Performance in Treating Axial Back Pain 57
9 Pipeline Assessment 58
10 Clinical Trial Analysis 61
11 Current and Future Players 63
11.1 Overview 63
11.2 Trends in Corporate Strategy 63
11.3 Company Profiles 63
11.3.1 Aesculap 63
11.3.2 Alphatec Spine 66
11.3.3 Amedica Corporation 69
11.3.4 Medtronic Spinal and Biologics 71
11.3.5 DePuy Spine 74
11.3.6 Globus Medical 77
11.3.7 K2M 80
11.3.8 Biomet 83
11.3.9 Stryker 86
11.3.10 Zimmer 89
11.3.11 Nuvasive 93
11.3.12 Orthofix 96
11.3.13 Integra LifeSciences 99
12 Market Outlook 103
12.1 Company Market Share 103
12.2 US 104
13 Appendix 106
13.1 Bibliography 106
13.2 Abbreviations 116
13.3 Report Methodology 117
13.3.1 Overview 117
13.3.2 Coverage 117
13.3.3 Primary Research 117
13.3.4 Secondary Research 118
13.3.5 Forecasting Methodology 119
13.4 Key Opinion Leaders Included in this Study 120
13.5 About the Authors 121
13.5.1 Joseph A. Gregory, Analyst, Surgical Devices 121
13.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 121
13.6 Global Head of Healthcare 122
13.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 122
13.7 About MediPoint 123
13.8 About GlobalData 123
13.9 Disclaimer 123

1.1 List of Tables

Table 1: Indications for Lumbar Spinal Fusion 15
Table 2: Adoption of Spinal Fusion and Spinal Non-Fusion, US, 2013 and 2020 20
Table 3: Mergers and Acquisitions, 2010-2014 28
Table 4: Population Aged 60 Years Old or Over, 1950-2050 (in millions) (percentage in older ages) 45
Table 5: Overall Perceived Advantages of Minimally Invasive Surgery Techniques, 2007 51
Table 6: Overall Perceived Limitations of Minimally Invasive Surgery Techniques, 2007 51
Table 7: Company Portfolio - Aesculap 64
Table 8: Product Portfolio - Aesculap 65
Table 9: Company Portfolio - Alphatec Spine 67
Table 10: Product Portfolio - Alphatec Spine 68
Table 11: Company Portfolio - Amedica 70
Table 12: Product Portfolio - Amedica 71
Table 13: Company Portfolio - Medtronic Spinal and Biologics 72
Table 14: Product Portfolio - Medtronic Spinal and Biologics 73
Table 15: Company Portfolio - DePuy Spine 75
Table 16: Product Portfolio - DePuy Spine 76
Table 17: Company Portfolio - Globus Medical 78
Table 18: Product Portfolio - Globus Medical 79
Table 19: Company Portfolio - K2M 81
Table 20: Product Portfolio - K2M 82
Table 21: Company Portfolio - Biomet 84
Table 22: Product Portfolio - Biomet 85
Table 23: Company Portfolio - Stryker 87
Table 24: Product Portfolio - Stryker 88
Table 25: Company Portfolio - Zimmer 91
Table 26: Product Portfolio - Zimmer 92
Table 27: Company Portfolio - Nuvasive 94
Table 28: Product Portfolio - Nuvasive 95
Table 29: Company Portfolio - Orthofix 97
Table 30: Product Portfolio - Orthofix 98
Table 31: Company Portfolio - Integra LifeSciences 100
Table 32: Product Portfolio - Integra LifeSciences 101
Table 33: Spinal Surgery, US Company Market Share, 2012 103
Table 34: US Spinal Fusion Sales ($m) Forecast, 2011-2020 105

1.2 List of Figures

Figure 1: Spinal Fusion Procedure Volumes, US, 2011-2020 21
Figure 2: Adoption of Spinal Implants for the Fusion Procedures, US, 2013 23
Figure 3: Spinal Fusion Procedure Volumes, US, 2002-2011 32
Figure 4: Spinal Surgery, US Company Market Share, 2012 104
Figure 5: US Spinal Fusion Sales ($m) Forecast, 2011-2020 105

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

2016 Hematology and Flow Cytometry Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test, Technology Trends, Opportunities for Suppliers

  • $ 33500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 33-country survey from VPGMarketResearch.com contains over 900 pages, 380 tables and provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and ...

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

2016 Europe Microbiology Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnosti

  • $ 30000
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 820 pages and 418 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.